Astex Finds A Suitable Home As Otsuka Subsidiary
This article was originally published in The Pink Sheet Daily
Executive Summary
The California/U.K.-based biotech has announced plans to be acquired by Japanese pharma Otsuka in a deal that will please shareholders and provide its suitor with a slew of revenue-generating opportunities including a mid-stage pipeline, a platform technology and royalty streams.